rocuronium and Spinal-Muscular-Atrophies-of-Childhood

rocuronium has been researched along with Spinal-Muscular-Atrophies-of-Childhood* in 2 studies

Other Studies

2 other study(ies) available for rocuronium and Spinal-Muscular-Atrophies-of-Childhood

ArticleYear
[General anesthetic management of a patient with spinal muscular atrophy type III].
    Masui. The Japanese journal of anesthesiology, 2013, Volume: 62, Issue:6

    We report a 61-year-old woman (weight 49 kg, height 156 cm) with Kugelberg-Welander disease who was scheduled for bilateral mastectomy under general anesthesia. We administered rocuronium 10 mg (0.20 mg x kg(-1)) for tracheal intubation. After 80 min, train-of-four ratio (TOFR) was 46%. During the operation, we did not administer rocuronium. After surgery, TOFR was 62%. Therefore, we administered sugammadex 100 mg (2 mg x kg(-1)). After 4 min, TOFR became above 90%, and the patient was extubated. There was no respiratory distress, muscle weakness, or neurologic untoward event after the use of sugammadex in the postoperative period. Sugammadex was effective in reversing rocuronium induced neuromuscular block in a patient with Kugelberg-Welander disease.

    Topics: Androstanols; Anesthesia, General; Female; gamma-Cyclodextrins; Humans; Intubation, Intratracheal; Mastectomy; Middle Aged; Neuromuscular Monitoring; Neuromuscular Nondepolarizing Agents; Rocuronium; Spinal Muscular Atrophies of Childhood; Sugammadex

2013
Reversal of neuromuscular blockade with sugammadex in a patient with spinal muscular atrophy type III (Kugelberg-Welander syndrome).
    Journal of anesthesia, 2012, Volume: 26, Issue:2

    Topics: Androstanols; gamma-Cyclodextrins; Humans; Male; Middle Aged; Neuromuscular Blockade; Piperidines; Propofol; Remifentanil; Rocuronium; Spinal Muscular Atrophies of Childhood; Sugammadex

2012